Summit Therapeutics (SMMT) had the lowest return in January 2023 by a large-cap US stock, returning -18.2%.
| ASSET | MONTH | % RETURN |
|---|---|---|
Summit Therapeutics (SMMT) | January 2023 | -18.2% |
Northrop Grumman (NOC) | January 2023 | -17.78% |
Texas Pacific Land Trust (TPL) | January 2023 | -13.49% |
Super Micro Computer (SMCI) | January 2023 | -12.94% |
Pfizer (PFE) | January 2023 | -12.63% |
Nextera Energy (NEE) | January 2023 | -11.54% |
Archer-Daniels-Midland (ADM) | January 2023 | -10.67% |
McCormick (MKC) | January 2023 | -9.76% |
Baxter International (BAX) | January 2023 | -9.35% |
Booz Allen Hamilton (BAH) | January 2023 | -9.21% |
Genmab A-S (GMAB) | January 2023 | -8.93% |
Intuitive Surgical (ISRG) | January 2023 | -8.87% |
Equinor ASA ADR (EQNR) | January 2023 | -8.44% |
ZoomInfo Technologies (GTM) | January 2023 | -7.96% |
AbbVie (ABBV) | January 2023 | -7.95% |
RPM International (RPM) | January 2023 | -7.84% |
Charles Schwab (SCHW) | January 2023 | -7.36% |
Johnson & Johnson (JNJ) | January 2023 | -7.23% |
Logitech International (LOGI) | January 2023 | -7.1% |
Xylem (XYL) | January 2023 | -7.03% |
Centene (CNC) | January 2023 | -7.02% |
Neurocrine Biosciences (NBIX) | January 2023 | -6.99% |
Expand Energy (EXE) | January 2023 | -6.82% |
Emerson Electric (EMR) | January 2023 | -6.6% |
DexCom (DXCM) | January 2023 | -6.31% |
Large-cap stocks are treated as having a market cap of $10B+.
